Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Performance
Open
0.00Prev. Close
0.00Volume
NATotal traded value
NAUpper Circuit
NALower Circuit
NAFundamentals
| Market Cap | ₹1,892Cr |
| ROE | 21.52% |
| P/E Ratio(TTM) | 44.60 |
| EPS(TTM) | 42.02 |
| P/B Ratio | 9.60 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.34 |
| Book Value | 195.25 |
| Debt to Equity | 0.67 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Beta Drugs
Beta Drugs Limited is an India-based company that is engaged in the business of manufacturing of oncology medicines. The Company offers a range of oncology products including tablets, capsules and injections. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, brain, bone, lung, mouth, head and neck, prostate, leukemia, lymphoma and supportive cancer and others. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ADTHAL, Triodelta and others.;
| Parent Organisation | Beta Drugs Limited |
| Managing Director | Mr. Vijay Batra |
| NSE Symbol | BETA |
Shareholding Pattern
Sep '24
Nov '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 70.43 | ||
| Neuland Laboratories | NA (0.00%) | 98.02 | ||
| Jubilant Pharmova | NA (0.00%) | 35.29 | ||
| Acutaas Chemicals | NA (0.00%) | 60.86 |